- Home
- SGHT vs CURR Comparison
SGHT vs CURR Comparison
Compare SGHT & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- CURR
- Stock Information
- Founded
- SGHT 2011
- CURR 2013
- Country
- SGHT United States
- CURR Singapore
- Employees
- SGHT N/A
- CURR N/A
- Industry
- SGHT Medical Specialities
- CURR Business Services
- Sector
- SGHT Health Care
- CURR Consumer Discretionary
- Exchange
- SGHT Nasdaq
- CURR Nasdaq
- Market Cap
- SGHT 140.1M
- CURR 133.1M
- IPO Year
- SGHT 2021
- CURR N/A
- Fundamental
- Price
- SGHT $2.53
- CURR $1.83
- Analyst Decision
- SGHT Buy
- CURR
- Analyst Count
- SGHT 7
- CURR 0
- Target Price
- SGHT $4.68
- CURR N/A
- AVG Volume (30 Days)
- SGHT 195.9K
- CURR 569.7K
- Earning Date
- SGHT 03-05-2025
- CURR 03-04-2025
- Dividend Yield
- SGHT N/A
- CURR N/A
- EPS Growth
- SGHT N/A
- CURR N/A
- EPS
- SGHT N/A
- CURR N/A
- Revenue
- SGHT $79,543,000.00
- CURR $48,723,898.00
- Revenue This Year
- SGHT $1.23
- CURR N/A
- Revenue Next Year
- SGHT $0.34
- CURR N/A
- P/E Ratio
- SGHT N/A
- CURR N/A
- Revenue Growth
- SGHT N/A
- CURR N/A
- 52 Week Low
- SGHT $2.50
- CURR $1.19
- 52 Week High
- SGHT $8.45
- CURR $7.08
- Technical
- Relative Strength Index (RSI)
- SGHT 35.62
- CURR N/A
- Support Level
- SGHT $2.59
- CURR N/A
- Resistance Level
- SGHT $2.87
- CURR N/A
- Average True Range (ATR)
- SGHT 0.18
- CURR 0.00
- MACD
- SGHT 0.02
- CURR 0.00
- Stochastic Oscillator
- SGHT 6.74
- CURR 0.00
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants world-wide, delivering frictionless interoperable real-time fund transfers and instant messaging.